[Combined therapy of oral kanendomycin, azobenzene and phosphatidylcholine in bacillary dysentery and other infectious diarrheal diseases].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001391:Azo Compounds / Q000008:administration & dosage* / Q000627:therapeutic use*; D003510:Cyclohexanes / Q000627:therapeutic use; D003967:Diarrhea / Q000188:drug therapy*; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D004926:Escherichia coli / Q000187:drug effects; D006027:Glycosides / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D010713:Phosphatidylcholines / Q000008:administration & dosage* / Q000627:therapeutic use*; D012475:Salmonella / Q000187:drug effects; D012760:Shigella / Q000187:drug effects
D000900:Anti-Bacterial Agents; D001391:Azo Compounds; D003510:Cyclohexanes; D006027:Glycosides; D010713:Phosphatidylcholines